- Home
- IOBT vs GECC Comparison
IOBT vs GECC Comparison
Compare IOBT & GECC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOBT
- GECC
- Stock Information
- Founded
- IOBT 2014
- GECC 2016
- Country
- IOBT Denmark
- GECC United States
- Employees
- IOBT N/A
- GECC N/A
- Industry
- IOBT Biotechnology: Pharmaceutical Preparations
- GECC Finance: Consumer Services
- Sector
- IOBT Health Care
- GECC Finance
- Exchange
- IOBT Nasdaq
- GECC Nasdaq
- Market Cap
- IOBT 114.6M
- GECC 127.9M
- IPO Year
- IOBT 2021
- GECC N/A
- Fundamental
- Price
- IOBT $1.62
- GECC $11.33
- Analyst Decision
- IOBT Strong Buy
- GECC Strong Buy
- Analyst Count
- IOBT 2
- GECC 1
- Target Price
- IOBT $8.00
- GECC $11.50
- AVG Volume (30 Days)
- IOBT 1.1M
- GECC 161.3K
- Earning Date
- IOBT 11-11-2025
- GECC 10-30-2025
- Dividend Yield
- IOBT N/A
- GECC 13.54%
- EPS Growth
- IOBT N/A
- GECC 29.91
- EPS
- IOBT N/A
- GECC 1.58
- Revenue
- IOBT N/A
- GECC $47,638,000.00
- Revenue This Year
- IOBT N/A
- GECC $28.14
- Revenue Next Year
- IOBT N/A
- GECC N/A
- P/E Ratio
- IOBT N/A
- GECC $7.13
- Revenue Growth
- IOBT N/A
- GECC 29.12
- 52 Week Low
- IOBT $0.66
- GECC $8.87
- 52 Week High
- IOBT $2.79
- GECC $11.45
- Technical
- Relative Strength Index (RSI)
- IOBT 44.35
- GECC 58.13
- Support Level
- IOBT $1.71
- GECC $10.79
- Resistance Level
- IOBT $2.08
- GECC $11.45
- Average True Range (ATR)
- IOBT 0.15
- GECC 0.18
- MACD
- IOBT -0.01
- GECC -0.02
- Stochastic Oscillator
- IOBT 16.36
- GECC 81.95
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
About GECC Great Elm Capital Corp.
Great Elm Capital Corp is an externally managed, non-diversified closed-end management investment company. It generate both income and capital appreciation through debt and income-generating equity investments, including investments in finance businesses.